Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025 under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.